nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—embryo—liver cancer	0.0322	0.721	CbGeAlD
Pentosan Polysulfate—FGF1—embryo—liver cancer	0.00852	0.191	CbGeAlD
Pentosan Polysulfate—Mouth ulceration—Sorafenib—liver cancer	0.00458	0.02	CcSEcCtD
Pentosan Polysulfate—Prothrombin level increased—Epirubicin—liver cancer	0.00456	0.0199	CcSEcCtD
Pentosan Polysulfate—Prothrombin level increased—Doxorubicin—liver cancer	0.00422	0.0184	CcSEcCtD
Pentosan Polysulfate—FGF1—liver—liver cancer	0.00394	0.0882	CbGeAlD
Pentosan Polysulfate—Mood swings—Sorafenib—liver cancer	0.00348	0.0152	CcSEcCtD
Pentosan Polysulfate—Dehydration—Sorafenib—liver cancer	0.00342	0.0149	CcSEcCtD
Pentosan Polysulfate—Gingival bleeding—Epirubicin—liver cancer	0.0033	0.0144	CcSEcCtD
Pentosan Polysulfate—Gastritis—Sorafenib—liver cancer	0.00325	0.0142	CcSEcCtD
Pentosan Polysulfate—Lacrimation—Epirubicin—liver cancer	0.00318	0.0139	CcSEcCtD
Pentosan Polysulfate—Pelvic pain—Epirubicin—liver cancer	0.00308	0.0134	CcSEcCtD
Pentosan Polysulfate—Gingival bleeding—Doxorubicin—liver cancer	0.00305	0.0133	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Sorafenib—liver cancer	0.00305	0.0133	CcSEcCtD
Pentosan Polysulfate—Optic neuritis—Epirubicin—liver cancer	0.00304	0.0133	CcSEcCtD
Pentosan Polysulfate—Lacrimation—Doxorubicin—liver cancer	0.00294	0.0128	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Sorafenib—liver cancer	0.00287	0.0125	CcSEcCtD
Pentosan Polysulfate—Pelvic pain—Doxorubicin—liver cancer	0.00285	0.0124	CcSEcCtD
Pentosan Polysulfate—Optic neuritis—Doxorubicin—liver cancer	0.00281	0.0123	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Sorafenib—liver cancer	0.00276	0.012	CcSEcCtD
Pentosan Polysulfate—Jaundice—Sorafenib—liver cancer	0.00276	0.012	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Sorafenib—liver cancer	0.00267	0.0116	CcSEcCtD
Pentosan Polysulfate—Nystagmus—Epirubicin—liver cancer	0.00262	0.0114	CcSEcCtD
Pentosan Polysulfate—Nystagmus—Doxorubicin—liver cancer	0.00242	0.0106	CcSEcCtD
Pentosan Polysulfate—Amblyopia—Epirubicin—liver cancer	0.00242	0.0106	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Sorafenib—liver cancer	0.00237	0.0103	CcSEcCtD
Pentosan Polysulfate—Alopecia—Sorafenib—liver cancer	0.00225	0.0098	CcSEcCtD
Pentosan Polysulfate—Amblyopia—Doxorubicin—liver cancer	0.00224	0.00978	CcSEcCtD
Pentosan Polysulfate—Amenorrhoea—Epirubicin—liver cancer	0.00213	0.00929	CcSEcCtD
Pentosan Polysulfate—Rectal haemorrhage—Epirubicin—liver cancer	0.00207	0.00903	CcSEcCtD
Pentosan Polysulfate—Anaemia—Sorafenib—liver cancer	0.00205	0.00892	CcSEcCtD
Pentosan Polysulfate—Lacrimation increased—Epirubicin—liver cancer	0.00203	0.00885	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Sorafenib—liver cancer	0.00198	0.00864	CcSEcCtD
Pentosan Polysulfate—Amenorrhoea—Doxorubicin—liver cancer	0.00197	0.00859	CcSEcCtD
Pentosan Polysulfate—Rectal haemorrhage—Doxorubicin—liver cancer	0.00192	0.00836	CcSEcCtD
Pentosan Polysulfate—Myalgia—Sorafenib—liver cancer	0.00188	0.00822	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Sorafenib—liver cancer	0.00188	0.00822	CcSEcCtD
Pentosan Polysulfate—Lacrimation increased—Doxorubicin—liver cancer	0.00188	0.00819	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Epirubicin—liver cancer	0.00187	0.00816	CcSEcCtD
Pentosan Polysulfate—Colitis—Epirubicin—liver cancer	0.0018	0.00783	CcSEcCtD
Pentosan Polysulfate—Infection—Sorafenib—liver cancer	0.00179	0.00782	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Sorafenib—liver cancer	0.00177	0.00771	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Epirubicin—liver cancer	0.00177	0.0077	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Doxorubicin—liver cancer	0.00173	0.00755	CcSEcCtD
Pentosan Polysulfate—Anorexia—Sorafenib—liver cancer	0.00172	0.00751	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Epirubicin—liver cancer	0.00171	0.00746	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Epirubicin—liver cancer	0.00169	0.00738	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Epirubicin—liver cancer	0.00169	0.00738	CcSEcCtD
Pentosan Polysulfate—Colitis—Doxorubicin—liver cancer	0.00166	0.00725	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00165	0.00718	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Doxorubicin—liver cancer	0.00163	0.00713	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Sorafenib—liver cancer	0.00161	0.00702	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Sorafenib—liver cancer	0.00159	0.00693	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Doxorubicin—liver cancer	0.00158	0.0069	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Sorafenib—liver cancer	0.00157	0.00685	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Doxorubicin—liver cancer	0.00157	0.00683	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Doxorubicin—liver cancer	0.00157	0.00683	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Epirubicin—liver cancer	0.00155	0.00674	CcSEcCtD
Pentosan Polysulfate—Constipation—Sorafenib—liver cancer	0.00154	0.00674	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Sorafenib—liver cancer	0.00148	0.00644	CcSEcCtD
Pentosan Polysulfate—Urticaria—Sorafenib—liver cancer	0.00144	0.00626	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Doxorubicin—liver cancer	0.00143	0.00624	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Sorafenib—liver cancer	0.00143	0.00623	CcSEcCtD
Pentosan Polysulfate—Affect lability—Epirubicin—liver cancer	0.00134	0.00583	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Sorafenib—liver cancer	0.00133	0.0058	CcSEcCtD
Pentosan Polysulfate—Mood swings—Epirubicin—liver cancer	0.00129	0.00561	CcSEcCtD
Pentosan Polysulfate—Pruritus—Sorafenib—liver cancer	0.00128	0.00557	CcSEcCtD
Pentosan Polysulfate—Dehydration—Epirubicin—liver cancer	0.00126	0.00551	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Epirubicin—liver cancer	0.00125	0.00547	CcSEcCtD
Pentosan Polysulfate—Affect lability—Doxorubicin—liver cancer	0.00124	0.00539	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Sorafenib—liver cancer	0.00124	0.00539	CcSEcCtD
Pentosan Polysulfate—Gastritis—Epirubicin—liver cancer	0.0012	0.00524	CcSEcCtD
Pentosan Polysulfate—Dizziness—Sorafenib—liver cancer	0.00119	0.00521	CcSEcCtD
Pentosan Polysulfate—Mood swings—Doxorubicin—liver cancer	0.00119	0.00519	CcSEcCtD
Pentosan Polysulfate—Dehydration—Doxorubicin—liver cancer	0.00117	0.0051	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Doxorubicin—liver cancer	0.00116	0.00506	CcSEcCtD
Pentosan Polysulfate—Vomiting—Sorafenib—liver cancer	0.00115	0.00501	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Epirubicin—liver cancer	0.00114	0.00499	CcSEcCtD
Pentosan Polysulfate—Rash—Sorafenib—liver cancer	0.00114	0.00497	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Sorafenib—liver cancer	0.00114	0.00496	CcSEcCtD
Pentosan Polysulfate—Headache—Sorafenib—liver cancer	0.00113	0.00493	CcSEcCtD
Pentosan Polysulfate—Gastritis—Doxorubicin—liver cancer	0.00111	0.00485	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Epirubicin—liver cancer	0.00108	0.00473	CcSEcCtD
Pentosan Polysulfate—Nausea—Sorafenib—liver cancer	0.00107	0.00468	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Epirubicin—liver cancer	0.00107	0.00467	CcSEcCtD
Pentosan Polysulfate—Weight increased—Epirubicin—liver cancer	0.00107	0.00466	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Epirubicin—liver cancer	0.00106	0.00463	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Doxorubicin—liver cancer	0.00106	0.00461	CcSEcCtD
Pentosan Polysulfate—Jaundice—Epirubicin—liver cancer	0.00102	0.00445	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Epirubicin—liver cancer	0.00102	0.00445	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Epirubicin—liver cancer	0.00102	0.00444	CcSEcCtD
Pentosan Polysulfate—Sweating—Epirubicin—liver cancer	0.001	0.00438	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Doxorubicin—liver cancer	0.001	0.00438	CcSEcCtD
Pentosan Polysulfate—Haematuria—Epirubicin—liver cancer	0.000998	0.00435	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Doxorubicin—liver cancer	0.000991	0.00432	CcSEcCtD
Pentosan Polysulfate—Weight increased—Doxorubicin—liver cancer	0.000989	0.00431	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Epirubicin—liver cancer	0.000987	0.0043	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Doxorubicin—liver cancer	0.000983	0.00428	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Epirubicin—liver cancer	0.000982	0.00428	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Doxorubicin—liver cancer	0.000944	0.00412	CcSEcCtD
Pentosan Polysulfate—Jaundice—Doxorubicin—liver cancer	0.000944	0.00412	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Epirubicin—liver cancer	0.000942	0.00411	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Doxorubicin—liver cancer	0.000941	0.0041	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Epirubicin—liver cancer	0.000933	0.00407	CcSEcCtD
Pentosan Polysulfate—Sweating—Doxorubicin—liver cancer	0.000928	0.00405	CcSEcCtD
Pentosan Polysulfate—Haematuria—Doxorubicin—liver cancer	0.000923	0.00403	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Doxorubicin—liver cancer	0.000913	0.00398	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Doxorubicin—liver cancer	0.000909	0.00396	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Epirubicin—liver cancer	0.000876	0.00382	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Doxorubicin—liver cancer	0.000872	0.0038	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Doxorubicin—liver cancer	0.000863	0.00376	CcSEcCtD
Pentosan Polysulfate—Alopecia—Epirubicin—liver cancer	0.00083	0.00362	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Doxorubicin—liver cancer	0.000811	0.00353	CcSEcCtD
Pentosan Polysulfate—Flatulence—Epirubicin—liver cancer	0.000806	0.00351	CcSEcCtD
Pentosan Polysulfate—Alopecia—Doxorubicin—liver cancer	0.000768	0.00335	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Epirubicin—liver cancer	0.000759	0.00331	CcSEcCtD
Pentosan Polysulfate—Anaemia—Epirubicin—liver cancer	0.000756	0.0033	CcSEcCtD
Pentosan Polysulfate—Agitation—Epirubicin—liver cancer	0.000752	0.00328	CcSEcCtD
Pentosan Polysulfate—Flatulence—Doxorubicin—liver cancer	0.000746	0.00325	CcSEcCtD
Pentosan Polysulfate—Malaise—Epirubicin—liver cancer	0.000738	0.00322	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Epirubicin—liver cancer	0.000732	0.00319	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Doxorubicin—liver cancer	0.000702	0.00306	CcSEcCtD
Pentosan Polysulfate—Anaemia—Doxorubicin—liver cancer	0.0007	0.00305	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Epirubicin—liver cancer	0.000696	0.00304	CcSEcCtD
Pentosan Polysulfate—Myalgia—Epirubicin—liver cancer	0.000696	0.00304	CcSEcCtD
Pentosan Polysulfate—Agitation—Doxorubicin—liver cancer	0.000696	0.00303	CcSEcCtD
Pentosan Polysulfate—Discomfort—Epirubicin—liver cancer	0.000688	0.003	CcSEcCtD
Pentosan Polysulfate—Malaise—Doxorubicin—liver cancer	0.000683	0.00298	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Doxorubicin—liver cancer	0.000677	0.00295	CcSEcCtD
Pentosan Polysulfate—Oedema—Epirubicin—liver cancer	0.000668	0.00291	CcSEcCtD
Pentosan Polysulfate—Infection—Epirubicin—liver cancer	0.000663	0.00289	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Epirubicin—liver cancer	0.000654	0.00285	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Epirubicin—liver cancer	0.000645	0.00281	CcSEcCtD
Pentosan Polysulfate—Myalgia—Doxorubicin—liver cancer	0.000644	0.00281	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Doxorubicin—liver cancer	0.000644	0.00281	CcSEcCtD
Pentosan Polysulfate—Discomfort—Doxorubicin—liver cancer	0.000637	0.00278	CcSEcCtD
Pentosan Polysulfate—Anorexia—Epirubicin—liver cancer	0.000636	0.00277	CcSEcCtD
Pentosan Polysulfate—Oedema—Doxorubicin—liver cancer	0.000618	0.00269	CcSEcCtD
Pentosan Polysulfate—Infection—Doxorubicin—liver cancer	0.000614	0.00268	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000608	0.00265	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Doxorubicin—liver cancer	0.000605	0.00264	CcSEcCtD
Pentosan Polysulfate—Insomnia—Epirubicin—liver cancer	0.000604	0.00263	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Epirubicin—liver cancer	0.000599	0.00261	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Doxorubicin—liver cancer	0.000597	0.0026	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Epirubicin—liver cancer	0.000595	0.0026	CcSEcCtD
Pentosan Polysulfate—Anorexia—Doxorubicin—liver cancer	0.000589	0.00257	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Epirubicin—liver cancer	0.000588	0.00256	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Epirubicin—liver cancer	0.00058	0.00253	CcSEcCtD
Pentosan Polysulfate—Constipation—Epirubicin—liver cancer	0.000571	0.00249	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000563	0.00245	CcSEcCtD
Pentosan Polysulfate—Insomnia—Doxorubicin—liver cancer	0.000559	0.00244	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Doxorubicin—liver cancer	0.000555	0.00242	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Doxorubicin—liver cancer	0.000551	0.0024	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Epirubicin—liver cancer	0.00055	0.0024	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Epirubicin—liver cancer	0.000546	0.00238	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Doxorubicin—liver cancer	0.000544	0.00237	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Doxorubicin—liver cancer	0.000537	0.00234	CcSEcCtD
Pentosan Polysulfate—Urticaria—Epirubicin—liver cancer	0.00053	0.00231	CcSEcCtD
Pentosan Polysulfate—Constipation—Doxorubicin—liver cancer	0.000528	0.0023	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Epirubicin—liver cancer	0.000528	0.0023	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Doxorubicin—liver cancer	0.000509	0.00222	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Doxorubicin—liver cancer	0.000505	0.0022	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Epirubicin—liver cancer	0.000492	0.00214	CcSEcCtD
Pentosan Polysulfate—Urticaria—Doxorubicin—liver cancer	0.000491	0.00214	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Doxorubicin—liver cancer	0.000488	0.00213	CcSEcCtD
Pentosan Polysulfate—Pruritus—Epirubicin—liver cancer	0.000472	0.00206	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Epirubicin—liver cancer	0.000457	0.00199	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Doxorubicin—liver cancer	0.000455	0.00198	CcSEcCtD
Pentosan Polysulfate—Dizziness—Epirubicin—liver cancer	0.000441	0.00192	CcSEcCtD
Pentosan Polysulfate—Pruritus—Doxorubicin—liver cancer	0.000437	0.00191	CcSEcCtD
Pentosan Polysulfate—Vomiting—Epirubicin—liver cancer	0.000424	0.00185	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Doxorubicin—liver cancer	0.000423	0.00184	CcSEcCtD
Pentosan Polysulfate—Rash—Epirubicin—liver cancer	0.000421	0.00184	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Epirubicin—liver cancer	0.000421	0.00183	CcSEcCtD
Pentosan Polysulfate—Headache—Epirubicin—liver cancer	0.000418	0.00182	CcSEcCtD
Pentosan Polysulfate—Dizziness—Doxorubicin—liver cancer	0.000408	0.00178	CcSEcCtD
Pentosan Polysulfate—Nausea—Epirubicin—liver cancer	0.000397	0.00173	CcSEcCtD
Pentosan Polysulfate—Vomiting—Doxorubicin—liver cancer	0.000393	0.00171	CcSEcCtD
Pentosan Polysulfate—Rash—Doxorubicin—liver cancer	0.000389	0.0017	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Doxorubicin—liver cancer	0.000389	0.0017	CcSEcCtD
Pentosan Polysulfate—Headache—Doxorubicin—liver cancer	0.000387	0.00169	CcSEcCtD
Pentosan Polysulfate—Nausea—Doxorubicin—liver cancer	0.000367	0.0016	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—RAF1—liver cancer	0.00012	0.000166	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CDKN1A—liver cancer	0.00012	0.000166	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—BCL2L1—liver cancer	0.00012	0.000166	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—IL6—liver cancer	0.00012	0.000165	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CDKN1B—liver cancer	0.00012	0.000165	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CDKN1B—liver cancer	0.000119	0.000164	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—HRAS—liver cancer	0.000118	0.000163	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—IL6—liver cancer	0.000118	0.000163	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MTOR—liver cancer	0.000118	0.000162	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PIK3CB—liver cancer	0.000118	0.000162	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—MAPK8—liver cancer	0.000117	0.000162	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL2—liver cancer	0.000117	0.000161	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KDR—liver cancer	0.000117	0.000161	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—H2AFX—liver cancer	0.000117	0.000161	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MTHFR—liver cancer	0.000116	0.00016	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK14—liver cancer	0.000116	0.00016	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TERT—liver cancer	0.000116	0.000159	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CDKN1A—liver cancer	0.000115	0.000159	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CDKN1B—liver cancer	0.000114	0.000157	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—JUN—liver cancer	0.000114	0.000157	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK14—liver cancer	0.000114	0.000157	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ESR1—liver cancer	0.000114	0.000157	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—JUN—liver cancer	0.000113	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CTNNB1—liver cancer	0.000113	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—F2—liver cancer	0.000112	0.000155	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CTNNB1—liver cancer	0.000112	0.000155	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—VEGFA—liver cancer	0.000112	0.000154	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—STAT3—liver cancer	0.000111	0.000153	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—AKT1—liver cancer	0.000111	0.000152	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CDKN1B—liver cancer	0.00011	0.000152	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CDKN1A—liver cancer	0.00011	0.000152	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CDKN1A—liver cancer	0.00011	0.000151	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—BCL2L1—liver cancer	0.00011	0.000151	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—AKT1—liver cancer	0.000109	0.00015	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—MAPK8—liver cancer	0.000108	0.000148	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CG—liver cancer	0.000107	0.000148	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—APC—liver cancer	0.000107	0.000148	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—MAPK8—liver cancer	0.000107	0.000147	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MTHFR—liver cancer	0.000106	0.000146	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TERT—liver cancer	0.000105	0.000145	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CDKN1A—liver cancer	0.000105	0.000145	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—AKT1—liver cancer	0.000105	0.000144	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CTNNB1—liver cancer	0.000104	0.000144	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK14—liver cancer	0.000104	0.000143	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PRKCE—liver cancer	0.000103	0.000141	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TGFB1—liver cancer	0.000103	0.000141	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CDKN1A—liver cancer	0.000102	0.00014	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—BRAF—liver cancer	0.000101	0.000139	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—STAT3—liver cancer	9.84e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—APC—liver cancer	9.74e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF2—liver cancer	9.73e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDH1—liver cancer	9.71e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TNF—liver cancer	9.59e-05	0.000132	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—KRAS—liver cancer	9.51e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CD—liver cancer	9.45e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PRKCE—liver cancer	9.36e-05	0.000129	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SERPINE1—liver cancer	9.34e-05	0.000129	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CD—liver cancer	9.27e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—KRAS—liver cancer	9.21e-05	0.000127	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—BRAF—liver cancer	9.16e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—STAT3—liver cancer	9.09e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CSF2—liver cancer	9.08e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—H2AFX—liver cancer	8.95e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APC—liver cancer	8.88e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF2—liver cancer	8.87e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDH1—liver cancer	8.85e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KRAS—liver cancer	8.84e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CD—liver cancer	8.56e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SERPINE1—liver cancer	8.47e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PIK3CA—liver cancer	8.46e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CD—liver cancer	8.46e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KRAS—liver cancer	8.45e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MYC—liver cancer	8.44e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RAF1—liver cancer	8.43e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—TGFB1—liver cancer	8.42e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KRAS—liver cancer	8.4e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—BRAF—liver cancer	8.35e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CSF2—liver cancer	8.28e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—RAF1—liver cancer	8.28e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MTOR—liver cancer	8.23e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CB—liver cancer	8.23e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—H2AFX—liver cancer	8.16e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PIK3CA—liver cancer	8.12e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TERT—liver cancer	8.1e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MTOR—liver cancer	8.08e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CB—liver cancer	8.08e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—HRAS—liver cancer	8.08e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KRAS—liver cancer	8.06e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—HRAS—liver cancer	7.83e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CD—liver cancer	7.81e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KRAS—liver cancer	7.8e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PIK3CA—liver cancer	7.76e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—IL6—liver cancer	7.74e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1B—liver cancer	7.73e-05	0.000106	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SERPINE1—liver cancer	7.72e-05	0.000106	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PIK3CA—liver cancer	7.72e-05	0.000106	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—RAF1—liver cancer	7.64e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1B—liver cancer	7.59e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CASP3—liver cancer	7.57e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL2—liver cancer	7.56e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—RAF1—liver cancer	7.55e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HRAS—liver cancer	7.52e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—IL6—liver cancer	7.49e-05	0.000103	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MTOR—liver cancer	7.46e-05	0.000103	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CB—liver cancer	7.46e-05	0.000103	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL2—liver cancer	7.42e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PIK3CA—liver cancer	7.41e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KDR—liver cancer	7.4e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TERT—liver cancer	7.38e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCND1—liver cancer	7.37e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CB—liver cancer	7.37e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MTOR—liver cancer	7.37e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—JUN—liver cancer	7.36e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK14—liver cancer	7.36e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CTNNB1—liver cancer	7.3e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—JUN—liver cancer	7.22e-05	9.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ESR1—liver cancer	7.22e-05	9.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HRAS—liver cancer	7.18e-05	9.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PIK3CA—liver cancer	7.17e-05	9.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CTNNB1—liver cancer	7.17e-05	9.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—liver cancer	7.16e-05	9.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HRAS—liver cancer	7.14e-05	9.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—liver cancer	7.14e-05	9.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1A—liver cancer	7.13e-05	9.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—F2—liver cancer	7.13e-05	9.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1B—liver cancer	7e-05	9.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1A—liver cancer	7e-05	9.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—RAF1—liver cancer	6.97e-05	9.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK8—liver cancer	6.96e-05	9.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1B—liver cancer	6.92e-05	9.53e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—liver cancer	6.91e-05	9.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL6—liver cancer	6.87e-05	9.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HRAS—liver cancer	6.85e-05	9.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK8—liver cancer	6.83e-05	9.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—IL6—liver cancer	6.83e-05	9.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CG—liver cancer	6.82e-05	9.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APC—liver cancer	6.82e-05	9.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CB—liver cancer	6.81e-05	9.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MTOR—liver cancer	6.81e-05	9.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL2—liver cancer	6.77e-05	9.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KDR—liver cancer	6.75e-05	9.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK14—liver cancer	6.71e-05	9.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—liver cancer	6.64e-05	9.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HRAS—liver cancer	6.63e-05	9.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CTNNB1—liver cancer	6.62e-05	9.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—JUN—liver cancer	6.59e-05	9.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ESR1—liver cancer	6.58e-05	9.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CTNNB1—liver cancer	6.54e-05	9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—F2—liver cancer	6.5e-05	8.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1A—liver cancer	6.46e-05	8.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—liver cancer	6.43e-05	8.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—BRAF—liver cancer	6.41e-05	8.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1B—liver cancer	6.39e-05	8.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1A—liver cancer	6.38e-05	8.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—STAT3—liver cancer	6.36e-05	8.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—IL6—liver cancer	6.35e-05	8.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—liver cancer	6.34e-05	8.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—liver cancer	6.3e-05	8.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—STAT3—liver cancer	6.25e-05	8.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK8—liver cancer	6.23e-05	8.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CG—liver cancer	6.22e-05	8.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APC—liver cancer	6.22e-05	8.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—liver cancer	6.05e-05	8.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CTNNB1—liver cancer	6.03e-05	8.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CD—liver cancer	6e-05	8.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SERPINE1—liver cancer	5.93e-05	8.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MYC—liver cancer	5.91e-05	8.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TGFB1—liver cancer	5.9e-05	8.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1A—liver cancer	5.89e-05	8.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—liver cancer	5.86e-05	8.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BRAF—liver cancer	5.85e-05	8.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—STAT3—liver cancer	5.77e-05	7.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—STAT3—liver cancer	5.7e-05	7.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CD—liver cancer	5.47e-05	7.53e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KRAS—liver cancer	5.46e-05	7.53e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SERPINE1—liver cancer	5.41e-05	7.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KRAS—liver cancer	5.36e-05	7.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MYC—liver cancer	5.36e-05	7.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RAF1—liver cancer	5.35e-05	7.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TGFB1—liver cancer	5.35e-05	7.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—STAT3—liver cancer	5.26e-05	7.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CB—liver cancer	5.23e-05	7.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MTOR—liver cancer	5.23e-05	7.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CA—liver cancer	5.02e-05	6.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KRAS—liver cancer	4.95e-05	6.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CA—liver cancer	4.93e-05	6.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1B—liver cancer	4.9e-05	6.76e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KRAS—liver cancer	4.89e-05	6.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MYC—liver cancer	4.89e-05	6.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RAF1—liver cancer	4.88e-05	6.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TGFB1—liver cancer	4.88e-05	6.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—liver cancer	4.86e-05	6.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CASP3—liver cancer	4.81e-05	6.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL2—liver cancer	4.8e-05	6.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CB—liver cancer	4.77e-05	6.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MTOR—liver cancer	4.77e-05	6.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCND1—liver cancer	4.68e-05	6.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—JUN—liver cancer	4.67e-05	6.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HRAS—liver cancer	4.64e-05	6.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CTNNB1—liver cancer	4.63e-05	6.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HRAS—liver cancer	4.56e-05	6.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CA—liver cancer	4.55e-05	6.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—liver cancer	4.54e-05	6.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1A—liver cancer	4.53e-05	6.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KRAS—liver cancer	4.52e-05	6.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CA—liver cancer	4.49e-05	6.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1B—liver cancer	4.47e-05	6.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6—liver cancer	4.44e-05	6.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK8—liver cancer	4.42e-05	6.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CASP3—liver cancer	4.38e-05	6.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL2—liver cancer	4.38e-05	6.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6—liver cancer	4.36e-05	6.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCND1—liver cancer	4.27e-05	5.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JUN—liver cancer	4.26e-05	5.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CTNNB1—liver cancer	4.23e-05	5.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HRAS—liver cancer	4.21e-05	5.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HRAS—liver cancer	4.16e-05	5.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CA—liver cancer	4.15e-05	5.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—liver cancer	4.14e-05	5.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1A—liver cancer	4.13e-05	5.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—liver cancer	4.1e-05	5.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—liver cancer	4.08e-05	5.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—STAT3—liver cancer	4.04e-05	5.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK8—liver cancer	4.03e-05	5.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6—liver cancer	4.03e-05	5.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—liver cancer	4.03e-05	5.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6—liver cancer	3.98e-05	5.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HRAS—liver cancer	3.84e-05	5.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MYC—liver cancer	3.75e-05	5.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TGFB1—liver cancer	3.74e-05	5.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—liver cancer	3.72e-05	5.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—liver cancer	3.72e-05	5.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—STAT3—liver cancer	3.68e-05	5.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6—liver cancer	3.67e-05	5.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—liver cancer	3.67e-05	5.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KRAS—liver cancer	3.47e-05	4.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MYC—liver cancer	3.42e-05	4.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TGFB1—liver cancer	3.41e-05	4.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—liver cancer	3.39e-05	4.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CA—liver cancer	3.19e-05	4.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KRAS—liver cancer	3.16e-05	4.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—liver cancer	3.08e-05	4.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HRAS—liver cancer	2.95e-05	4.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CA—liver cancer	2.91e-05	4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6—liver cancer	2.82e-05	3.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—liver cancer	2.81e-05	3.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HRAS—liver cancer	2.69e-05	3.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—liver cancer	2.6e-05	3.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6—liver cancer	2.57e-05	3.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—liver cancer	2.37e-05	3.27e-05	CbGpPWpGaD
